Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PEG3 (Paternally expressed gene 3) is an imprinted gene expressed only from the paternally inherited allele and encodes a nuclear protein with multiple C2H2 Kruppel-type zinc finger domains[2]. PEG3 acts as a transcription factor, binding DNA in a sequence-specific manner (consensus motif: AGTnnCnnnTGGCT) and regulates the expression of various target genes in pathways involving apoptosis, Wnt signaling, TNF signaling, cell growth, behavior, fat tissue homeostasis, and metabolic activity[2]. PEG3 knockout in mice leads to diverse phenotypes, including altered maternal behaviors, reduced offspring rearing, metabolic abnormalities, and muscle atrophy. It is considered important in placental mammals for developmental and behavioral adaptation[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Paternally expressed gene 3 (PEG3).